{"id":276454,"date":"2026-09-29T10:26:57","date_gmt":"2026-09-29T04:56:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=276454"},"modified":"2026-09-29T10:26:57","modified_gmt":"2026-09-29T04:56:57","slug":"why-bliss-gvs-pharma-share-price-price-fall-2026-09-29","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-bliss-gvs-pharma-share-price-price-fall-2026-09-29\/","title":{"rendered":"Bliss GVS Pharma (BLISSGVS-BE) Share Price Falls 5% Today"},"content":{"rendered":"
Bliss GVS Pharma (BLISSGVS-BE)<\/a> share price fell to Rs 700.75 today, down 5% from the previous close. Market cap was Rs 7,542.02 crore.<\/em><\/div>\n

Published:<\/strong>   29 September 2026 at 10:23:29 AM IST<\/p>\n

Bliss GVS Pharma Share Price fell sharply in today\u2019s session, with the stock closing at Rs 700.75 after a 5% decline. The company\u2019s market capitalisation stands at Rs 7,542.02 Cr, placing it in the Mid Cap category. Bliss GVS Pharma Share Price Today therefore reflects a clear one-day price fall rather than a change in the company\u2019s longer-term business profile. The data supplied for this move confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Bliss GVS Pharma Stock News, the key point is that today\u2019s trade reset the share price from Rs 737.60 to Rs 700.75. In this Univest note, we focus on the verified price action, the company\u2019s valuation metrics, its Healthcare sector context and how its numbers compare with listed pharmaceutical peers.<\/p>\n

Bliss GVS Pharma Share Price also matters for investors following Bliss GVS Pharma Share Price Today because the move came after an open at Rs 730.00 and a session high of Rs 730.00, while the low matched the closing price at Rs 700.75. That combination shows that the stock spent the day below its opening level and ended at the lowest point of the session. The exact turnover was Rs 3.45 Cr. Below, Univest breaks down what the decline shows, what the numbers say about Bliss GVS Pharma Stock Performance, and which verified fundamentals deserve attention next.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n